Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis (Q34830869)

4 August 2017

0 references

1 reference

title

Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis (English)

1 reference

4 August 2017

0 references

1 reference

1 reference

1 reference

John F Gleeson

5

0 references

Mario Alvarez-Jiménez

object named as

Mario Alvarez-Jiménez

series ordinal

1

0 references

Patrick McGorry

series ordinal

4

object named as

Patrick D McGorry

1 reference

4 August 2017

Alexandra G Parker

2

1 reference

PubMed ID

19900962

4 August 2017

Sarah E Hetrick

series ordinal

3

1 reference

PubMed ID

19900962

4 August 2017

language of work or name

English

0 references

publication date

9 November 2009

1 reference

4 August 2017

Schizophrenia Bulletin

1 reference

4 August 2017

37

1 reference

4 August 2017

3

1 reference

4 August 2017

619-630

1 reference

A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Differential predictors of critical comments and emotional over-involvement in first-episode psychosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 y

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Early intervention in psychosis: concepts, evidence and future directions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Psychosocial treatment for first-episode psychosis: a research update

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

A controlled trial of cognitively oriented psychotherapy for early psychosis (COPE) with four-year follow-up readmission data

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Pharmacological treatments for first-episode schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Schizophrenia and obesity: impact of antipsychotic medications.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Relapse in schizophrenia: costs, clinical outcomes and quality of life

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Practice guideline for the treatment of patients with schizophrenia, second edition.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

New generation antipsychotics for first episode schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Measuring inconsistency in meta-analyses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

At issue: predicting drug-free treatment response in acute psychosis from the Soteria project

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Treatment of acute psychosis without neuroleptics: two-year outcomes from the Soteria project

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Systematic reviews in health care: Assessing the quality of controlled clinical trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Early intervention in psychosis. The critical period hypothesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Meta-analysis: principles and procedures

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Bias in meta-analysis detected by a simple, graphical test

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

EPPIC: an evolving system of early detection and optimal management

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Treatment, expressed emotion and relapse in recent onset schizophrenic disorders.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Randomised-control trial of family intervention for 78 first-episode male schizophrenic patients. An 18-month study in Suzhou, Jiangsu

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Cost of relapse in schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Meta-analysis in clinical trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

The Scottish first episode schizophrenia study. VII. Two-year follow-up. Scottish Schizophrenia Research Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

The pilot project 'Soteria Berne'. Clinical experiences and results

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Olanzapine versus haloperidol treatment in first-episode psychosis

8 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Cognitive--behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

An RCT of early intervention in psychosis: Croydon Outreach and Assertive Support Team (COAST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

One-year outcome in first episode psychosis patients in the Swedish Parachute project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

The relationship between duration of untreated psychosis and outcome: an eight-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Developing services for first-episode psychosis and the critical period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

The Effect of Family Interventions on Relapse and Rehospitalization in Schizophrenia--A Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy.

21 January 2018

2 references

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs Chlorpromazine

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080698

Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project

26 October 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP129

The Scottish First Episode Schizophrenia Study V. One-year follow-up. The Scottish Schizophrenia Research Group

21 January 2018

1 reference

12 December 2020

Social functioning and the course of early-onset schizophrenia: five-year follow-up of a psychosocial intervention

1 reference

12 December 2020

Delay in treating schizophrenia may narrow therapeutic window of opportunity

1 reference

12 December 2020

A randomised controlled trial of prophylactic neuroleptic treatment

1 reference

12 December 2020

Remission in schizophrenia: Applying recent consensus criteria to refine the concept

1 reference

12 December 2020

Cognitive–behavioural therapy in first-episode and early schizophrenia

1 reference

12 December 2020

Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes

1 reference

12 December 2020

A pilot study evaluating the effectiveness of individual inpatient cognitive-behavioural therapy in early psychosis

1 reference

12 December 2020

Fluphenazine vs Placebo in Patients With Remitted, Acute First-Episode Schizophrenia

1 reference

12 December 2020

Shortened Duration of Untreated First Episode of Psychosis: Changes in Patient Characteristics at Treatment

1 reference

12 December 2020

A randomized controlled trial of a brief intervention for families of patients with a first episode of psychosis

1 reference

12 December 2020

Identifiers

DOI

10.1093/SCHBUL/SBP129

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

PubMed ID

19900962